Abstract
Background: Coronary artery calcium, a radiographic marker for atherosclerosis and a predictor of coronary heart disease (CHD), is less extensive in women than in men of the same age. The role of estrogen in the pathogenesis of coronary artery calcification is unknown. We examined the association of es- trogen status with extent of calcification and atherosclerotic plaque in coronary arteries of deceased women. Methods: Coronary arteries were obtained at autopsy from 56 white women age 18 -98 yr, 46 postmenopausal and 10 pre- menopausal. Exclusion criteria included patients with coro- nary stents, coronary artery bypass surgery, and medical- legal cases. Medical records were reviewed for demographics, CHD risk factors, menstrual status, and use of estrogen re- placement therapy. Contact microradiography of coronary arteries assessed true calcium content and atherosclerotic plaque area was analyzed histologically. Results: The coronary arteries from estrogen-treated post- menopausal women had lower mean coronary calcium con- tent (P 0.002), mean plaque area (P < 0.0001), and calcium- to-plaque area ratio (P 0.004) than those from untreated menopausal women. Estrogen status, age, diabetes, and hy- pertension predicted calcium and plaque area by univariate analysis. After controlling for these CHD risk factors, estrogen status remained an independent predictor of both calcium (P 0.014) and plaque area (P 0.001) in all women. Mean calcium area (P < 0.05) but not plaque area (P 0.44) was significantly greater in women treated with estrogen replace- ment therapy than in premenopausal women. Coronary cal- cium (P < 0.007) and plaque area (P < 0.03) varied significantly with age in untreated postmenopausal women, but not in the estrogen-treated or premenopausal women (P 0.33). Conclusions: Estrogen status is associated with coronary calcium and plaque area independent of age and CHD risk factors. Estrogen may modulate the calcium content of ath- erosclerotic plaques, as well as plaque area and may slow the progression of atherosclerosis in women. (J Clin Endocrinol Metab 87: 1062-1067, 2002)